Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.
A German study indicates that COVID-19 infection can cause increased sperm cell death, inflammation and oxidative stress, resulting in lower sperm quality and potentially reducing fertility.
A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.
With COVID-19 vaccinations set to roll out in less than one month, Australia's hospital pharmacists are preparing for their central role in the administration process.
A modelling study led by UNSW Sydney predicts that global demand for cancer surgery will rise by 52% within two decades, with low-income countries bearing the greatest burden.
A new immunotherapy treatment will be studied in clinical trials, with the aim of preventing dangerous side effects for children who have to undergo stem cell transplants.
The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY.
Achieving herd immunity for COVID-19 may be a challenge through current vaccination programs, research from the Imperial College London has found.
Researchers have developed biomechanical models that use mathematical- and physics-based representations of human movement to predict spinal loading.
Based on levels of a specific protein found in the brain, the test is reported to be the first of its kind in the world.
Heart Research Australia is encouraging Australians to wear red and donate during February, to raise awareness for heart disease and funds for life-saving research.
An international team of researchers, led by The University of Melbourne, has found two new mammogram-based measures for breast cancer risk.
An international study has uncovered new evidence of the positive role of androgens in breast cancer treatment.
The RACGP has welcomed government confirmation that GPs will be at the forefront of Australia's COVID-19 vaccine rollout.